MedPath

Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.

Terminated
Conditions
Cerebral Palsy
Pain
Children
Interventions
Device: Analgesia Nociception Index
Registration Number
NCT02364856
Lead Sponsor
University Hospital, Lille
Brief Summary

This study evaluates Analgesia Nociception Index (Heart Rate Variability based index) and its variations after painful stimulations in children with cerebral palsy : acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy).

Detailed Description

Cerebral Palsy (CP) is the most common cause of motor handicap in childhood. CP is caused by damage to the developing brain, resulting in limits in movement, posture, or communication ability. CP affects about one newborn on 450. Pain management is one of the major expectations of CP patients (La Foundation Motrice, 2009) but in this population, pain is not recognized and inadequately treated.

Autonomic nervous system (ANS) is the automatic part of our nervous system regulating vital functions like cardiac beats or respiration. It is divided in sympathetic and parasympathetic. Analysis of heart rate variability (HRV) allows isolation of variations due to parasympathetic and their study. Works from the CIC-IT 807 lead to creation of an index called ANI (Analgesia Nociception Index), which is very sensitive to pain. It is validated on adults (Jeanne, 2012). It could be helpful to assess pain in CP, particularly in patients with communication disabilities. It is important to study this new tool in CP children before developing clinical applications.

Main objective of this study is to demonstrate that ANI is relevant in CP children and that it is sensitive to pain like in adults. Population will be 40 CP children (6-18y) receiving rehabilitation therapy in specialized centres. Duration of the study is 2 years. Parent's consent should be obtained. Investigators will record heart rate of children in 3 conditions in their rehabilitation centres: usual position, acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy). Parameters will be calculated in CIC-IT 807 lab (heart rate, ANI). Values of ANI and heart rate before and after painful stimulations will be compared. Correlation between ANI and results of usual pain assessment tools (rFLACC scale, visual analog scale) or characteristics of the population will be analyzed.

Lille University Hospital and CIC-IT 807 lab will collaborate with 2 pediatric rehabilitation centers: Centre Marc Sautelet and Zuydcoote Hospital.

Expected result is that ANI is relevant to CP children. Clinical applications are multiple: pain assessment, adaptation of medical equipment.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Cerebral Palsy
  • Rehabilitation care with physiotherapy and/or toxinum botulinum injections
  • Absence of identified autonomic nervous system disease
  • Parental and children (if applicable) consent obtained
  • French National Health System cover
Exclusion Criteria
  • baseline Respiratory Frequency > 30/min
  • beta-blockers or atropinic treatment
  • Pacemaker, cardiac rhythm disease
  • Diabetes mellitus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Children with cerebral palsyAnalgesia Nociception Index-
Primary Outcome Measures
NameTimeMethod
Analgesia Nociception Index ANI before and after painful stimulation300 seconds before and 300 seconds after painful stimulation

ANI is calculated from heart rate recordings 300 seconds before and after painful stimulations and compared

Secondary Outcome Measures
NameTimeMethod
ANI at baseline300 seconds at rest

ANI calculated from Heart rate recordings during 300 seconds in patient's usual position

time for recovering10 minutes after painful stimulation

time for recovering baseline ANI after painful stimulation

pain score measured by Visual Analog Scaleimmediately after painful stimulation

when VAS will be applicable, children will be asked to score their pain with VAS scale; results of pain ratings with VAS will be compared to ANI results

dysautonomic symptomsinclusion

results of ANI measures will be compared between two groups according to presence or absence of dysautonomic symptoms

pain score measured by rFLACC scaleimmediately after painful stimulation

rFLACC scale will be scored immediately after painful stimulation; results of pain ratings with rFLACC will be compared to ANI results

Gross Motor Function Classification Systeminclusion

results of ANI measures will be compared to the severity of motor impairment through the Gross Motor Function Classification System

Trial Locations

Locations (3)

CHRU de Lille, Pôle Enfant, Hôpital Roger Salengro

🇫🇷

Lille, France

Centre de Réadaptation Fonctionnelle Marc Sautelet

🇫🇷

Villeneuve-d'Ascq, France

Hôpital maritime de Zuydcoote, Service de SSR Enfant

🇫🇷

Zuydcoote, France

© Copyright 2025. All Rights Reserved by MedPath